News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Simpson Jennifer K.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2023 |
4
| Simpson Jennifer K. (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns:
| Granted 16,253 options to buy
@ $26, valued at
$422.6k
|
|
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/15/2021 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Panbela Therapeutics, Inc.
Txns:
| Granted 19,125 options to buy
@ $2.26, valued at
$43.2k
|
|
04/01/2021 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Panbela Therapeutics, Inc.
Txns:
| Granted 170,000 options to buy
@ $4.09, valued at
$695.3k
|
|
02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/14/2020 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Sun BioPharma, Inc.
Txns:
| Bought 1,000 shares
@ $2.7371, valued at
$2.7k
|
|
09/01/2020 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Sun BioPharma, Inc.
Txns:
| Bought 2,424 shares
@ $0 Bought 2,424 warrants
@ $4.54, valued at
$11k
|
|
07/17/2020 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Sun BioPharma, Inc.
Txns:
| Granted 212,048 options to buy
@ $9.99, valued at
$2.1M
|
|
05/08/2020 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.
Txns:
| Granted 10,310 shares
@ $0 Converted 14,700 shares
@ $0 Converted 147 convertible preferred
@ $0 |
|
01/07/2020 |
4
| Simpson Jennifer K. (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $59.795, valued at
$598k
|
|
10/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2019 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.
Txns:
| Bought 147 convertible preferred
@ $1000, valued at
$147k
Bought 2,450,000 warrants
@ $0 |
|
02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/23/2018 |
4
| Simpson Jennifer K. (President & CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.
Txns:
| Bought 7,399 shares
@ $1.75, valued at
$12.9k
|
|
08/02/2018 |
4
| Simpson Jennifer K. (President & CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.
Txns:
| Bought 100 shares
@ $2.55, valued at
$255 |
|
06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/12/2015 |
4
| Simpson Jennifer K. (President & CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.
Txns:
| Granted 201,375 shares
@ $0 Granted 95,125 options to buy
@ $1.19, valued at
$113.2k
|
|
11/18/2013 |
4
| Simpson Jennifer K. (Interim Co-CEO&Pres.EVP Market) has filed a Form 4 on DELCATH SYSTEMS, INC.
Txns:
| Granted 185,997 options to buy
@ $0.3, valued at
$55.8k
|
|
03/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/04/2012 |
4
| Simpson Jennifer K. (Exec. VP, Global Marketing) has filed a Form 4 on DELCATH SYSTEMS INC
Txns:
| Bought 3,000 shares
@ $1.49, valued at
$4.5k
|
|
03/26/2012 |
4
| Simpson Jennifer K. (Exec. VP, Global Marketing) has filed a Form 4 on DELCATH SYSTEMS INC
Txns:
| Granted 7,500 shares
@ $0 Granted 60,000 options to buy
@ $3.17, valued at
$190.2k
|
|
|
|